208 related articles for article (PubMed ID: 24276042)
1. Hepatic sinusoidal obstruction syndrome during chemotherapy for childhood medulloblastoma: report of a case and review of the literature.
Kotecha RS; Buckland A; Phillips MB; Cole CH; Gottardo NG
J Pediatr Hematol Oncol; 2014 Jan; 36(1):76-80. PubMed ID: 24276042
[TBL] [Abstract][Full Text] [Related]
2. Hepatic Sinusoidal Obstruction Syndrome in a child after chemotherapy for medulloblastoma.
Ishaqi MK; Jamil A; Khanani M; Baroudi M; Trad O; El-Hayek M; Bouffet E
J Neurooncol; 2010 Mar; 97(1):137-41. PubMed ID: 19701718
[TBL] [Abstract][Full Text] [Related]
3. "Pre-emptive strike"-the case for early treatment of hepatic sinusoidal obstruction syndrome with defibrotide.
Rajagopal R; Phillips MB; Gottardo NG
Pediatr Blood Cancer; 2018 Jul; 65(7):e27036. PubMed ID: 29537138
[TBL] [Abstract][Full Text] [Related]
4. Severe Hepatic Sinusoidal Obstruction Syndrome in a Child Receiving Vincristine, Actinomycin-D, and Cyclophosphamide for Rhabdomyosarcoma: Successful Treatment with Defibrotide.
Choi A; Kang YK; Lim S; Kim DH; Lim JS; Lee JA
Cancer Res Treat; 2016 Oct; 48(4):1443-1447. PubMed ID: 27034141
[TBL] [Abstract][Full Text] [Related]
5. Sinusoidal Obstruction Syndrome During Chemotherapy of Pediatric Cancers and its Successful Management With Defibrotide.
Kizilocak H; Dikme G; Özdemir N; Kuruğoğlu S; Adaletli İ; Erkan T; Celkan T
J Pediatr Hematol Oncol; 2017 Oct; 39(7):e373-e376. PubMed ID: 28859028
[TBL] [Abstract][Full Text] [Related]
6. Defibrotide treatment but not prophylaxis is useful in hepatic sinusoidal obstruction syndrome in children undergoing autologous stem cell transplant following high-dose chemotherapy: A single-center experience from the Royal Marsden Hospital, UK.
Roy Moulik N; Johnson I; Van Bruggen L; Petterson T; Mycroft J; Vaidya SJ
Pediatr Blood Cancer; 2020 Nov; 67(11):e28677. PubMed ID: 32865880
[TBL] [Abstract][Full Text] [Related]
7. [Application of defibrotide in hepatic sinusoidal obstruction syndrome induced by hematopoietic stem cell transplantation].
Liu ZL; Wang Y; Liu YL; Zhang J
Zhonghua Gan Zang Bing Za Zhi; 2021 Jan; 29(1):92-96. PubMed ID: 33541030
[TBL] [Abstract][Full Text] [Related]
8. Clinical severe hepatic venoocclusive disease during induction treatment of acute monoblastic leukemia managed with defibrotide.
Bairey O; Kirgner I; Yakobi M; Hamdan A; Ben-Ari Z; Shaklai M
Am J Hematol; 2002 Apr; 69(4):281-4. PubMed ID: 11921023
[TBL] [Abstract][Full Text] [Related]
9. Veno-occlusive disease of the liver during induction therapy for acute lymphoblastic leukemia.
Papadopoulos A; Ntaios G; Kaiafa G; Girtovitis F; Saouli Z; Kontoninas Z; Diamantidis MD; Savopoulos C; Hatzitolios A
Int J Hematol; 2008 Nov; 88(4):441-442. PubMed ID: 18839274
[TBL] [Abstract][Full Text] [Related]
10. Defibrotide for the treatment of hepatic veno-occlusive disease/sinusoidal obstruction syndrome following nontransplant-associated chemotherapy: Final results from a post hoc analysis of data from an expanded-access program.
Kernan NA; Richardson PG; Smith AR; Triplett BM; Antin JH; Lehmann L; Messinger Y; Liang W; Hume R; Tappe W; Soiffer RJ; Grupp SA
Pediatr Blood Cancer; 2018 Oct; 65(10):e27269. PubMed ID: 29873895
[TBL] [Abstract][Full Text] [Related]
11. Treatment of Sinusoidal Obstruction Syndrome With Defibrotide in Pediatric Cancer Patients Following Nontransplant-associated Chemotherapy: A Case Report and Review of the Literature.
Lawrence MR; Bassal M; Ramphal R; Johnston DL
J Pediatr Hematol Oncol; 2022 Apr; 44(3):e788-e791. PubMed ID: 33902061
[TBL] [Abstract][Full Text] [Related]
12. Veno-occlusive disease of the liver in a child after chemotherapy for brain tumor.
Elli M; Pinarli FG; Dagdemir A; Acar S
Pediatr Blood Cancer; 2006 Apr; 46(4):521-3. PubMed ID: 16317738
[TBL] [Abstract][Full Text] [Related]
13. Veno-occlusive disease in pediatric patients affected by Wilms tumor.
Cesaro S; Spiller M; Sartori MT; Alaggio R; Peruzzo M; Saggiorato G; Bisogno G
Pediatr Blood Cancer; 2011 Aug; 57(2):258-61. PubMed ID: 21246705
[TBL] [Abstract][Full Text] [Related]
14. Non-activated protein C rescue treatment in Wilms tumour associated hepatic sinusoidal obstructive syndrome.
De Leonardis F; Koronica R; Bruno SD; Santoro N
Pediatr Blood Cancer; 2014 May; 61(5):940-1. PubMed ID: 24281860
[TBL] [Abstract][Full Text] [Related]
15. Veno-occlusive disease in a child with rhabdomyosarcoma after conventional chemotherapy: report of a case and review of the literature.
Cecen E; Uysal KM; Ozguven A; Gunes D; Irken G; Olgun N
Pediatr Hematol Oncol; 2007 Dec; 24(8):615-21. PubMed ID: 18092252
[TBL] [Abstract][Full Text] [Related]
16. Defibrotide for children and adults with hepatic veno-occlusive disease post hematopoietic cell transplantation.
Corbacioglu S; Richardson PG
Expert Rev Gastroenterol Hepatol; 2017 Oct; 11(10):885-898. PubMed ID: 28825848
[TBL] [Abstract][Full Text] [Related]
17. Defibrotide Use in Vincristine-induced Hepatic Sinusoidal Obstruction Syndrome.
Tang C; Lindsay J; Gill A; Kerridge I
Clin Lymphoma Myeloma Leuk; 2017 Aug; 17(8):539-541. PubMed ID: 28842141
[No Abstract] [Full Text] [Related]
18. Defibrotide sodium for the treatment of hepatic veno-occlusive disease/sinusoidal obstruction syndrome.
Richardson PG; Triplett BM; Ho VT; Chao N; Dignan FL; Maglio M; Mohty M
Expert Rev Clin Pharmacol; 2018 Feb; 11(2):113-124. PubMed ID: 29301447
[TBL] [Abstract][Full Text] [Related]
19. BCSH/BSBMT guideline: diagnosis and management of veno-occlusive disease (sinusoidal obstruction syndrome) following haematopoietic stem cell transplantation.
Dignan FL; Wynn RF; Hadzic N; Karani J; Quaglia A; Pagliuca A; Veys P; Potter MN; ;
Br J Haematol; 2013 Nov; 163(4):444-57. PubMed ID: 24102514
[TBL] [Abstract][Full Text] [Related]
20. Pooled analysis of Day 100 survival for defibrotide-treated patients with hepatic veno-occlusive disease/sinusoidal obstruction syndrome and ventilator or dialysis dependence following haematopoietic cell transplantation.
Richardson PG; Smith AR; Kernan NA; Lehmann L; Soiffer RJ; Ryan RJ; Tappe W; Grupp S
Br J Haematol; 2020 Aug; 190(4):583-587. PubMed ID: 32157682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
